Flow Antigen Test News Today

It wont help protect you on the plane. there are other ways to encourage people to be vaccinated. i think youre seeing that right now. >> you were the testing czar. i know you have seen this announcement, you have been sort of studying it by the white house that they are purchasing an additional $1 billion in rapid tests. whats the significant of that? >> its very significant. we worked as hard as we could to develop rapid testing. the first was the card test of that lateral flow antigen test. w...

Avacta Group is developing novel cancer immunotherapies and powerful diagnostics based on its two proprietary platforms - Affimer ® biologics and pre|CISION™ tumour targeted chemotherapies.   The Affimer platform is an alternative to antibodies derived from a small human protein. Despite their shortcomings, antibodies currently dominate markets, such as diagnostics and therapeutics, worth in excess of $100bn. Affimer technology has been designed to address many of these n...